Autoimmune polyglandular syndrome Type 2: The tip of an iceberg?

Clinical and Experimental Immunology

Volumn 137, Issue 2, 2004, Pages 225-233

  Betterle, C ^a,b   Lazzarotto, F ^a   Presotto, F ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Autoimmune Addison's disease; Autoimmune polyglandular syndrome; Thyroid autoimmune disease; Type 1 diabetes mellitus

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; GLUCOCORTICOID; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INSULIN; THYROXINE;

ADDISON DISEASE; ALOPECIA; ANTIBODY SPECIFICITY; ATROPHIC GASTRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 2; CELIAC DISEASE; CELLULAR IMMUNITY; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; GENETIC SUSCEPTIBILITY; GONAD DYSFUNCTION; GRAVES DISEASE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; HYPOPARATHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MULTIPLE ENDOCRINE ADENOMATOSIS; MYASTHENIA GRAVIS; NONHUMAN; PATHOGENESIS; PERNICIOUS ANEMIA; PRIORITY JOURNAL; REVIEW; VITILIGO;

ADDISON DISEASE; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYENDOCRINOPATHIES, AUTOIMMUNE; THYROIDITIS, AUTOIMMUNE;

EID: 3543015625     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02561.x     Document Type: Review

References (94)

1. Oegle JW. On disease of the brain as result of diabetes mellitus. St George's Hosp Report 1866; 1:157-88.
2. Wehrmacher WH. Addison's disease with diabetes mellitus. Arch Int Med 1961; 108:182-8.
3. Schmidt MB. Eine biglandulare Erkrankung (Nebennieren und Schilddrüse) bei Morbus Addisonii. Verh Dtsch Ges Pathol 1926; 21:212-21.
4. Wells HG. Addison's disease with the selective destruction of the suprarenal cortex. Arch Pathol 1930; 10:499-523.
5. Rowntree LG, Snell AM. A Clinical Study of Addison's Disease. Mayo Clinic Monographs. Philadelphia: W.B. Saunders, 1931.
6. Gowen WM. Addison's disease with diabetes mellitus. N Engl J Med 1932; 207:577-9.
7. Beaven DW, Nelson Don H, Renold AE, Thorn GW. Diabetes mellitus and Addison's disease. N Engl J Med 1959; 261:443-54.
8. Solomon N, Carpenter CCJ, Bennet IL, JrMcGehee Harvey A. Schmidt's syndrome (thyroid and adrenal insufficiency) and coexistent diabetes mellitus. Diabetes 1965; 14:300-4.
9. Carpenter CCJ, Solomon N, Silverberg SG, Bledsoe T, Northcutt RC, Klinenberg JR, Bennett IL, McGehee Harvey A. Schmidt's syndrome (thyroid and adrenal insufficiency): a review of the literature and a report of fifteen new cases including ten instances of coexistent diabetes mellitus. Medicine 1964; 43:153-80.
10. Roitt IM, Doniach D, Campbell PN, Hudson RV. Autoantibodies in Hashimoto's disease. Lancet 1956; 2:820-1.
11. Adams DD, Purves HD. Abnormal responses in the assay of thyrotropins. Proc University Otago Meed School 1956; 34:11-2.
12. Kriss JP. Inactivation of long-acting thyroid stimulator (LATS) by anti-k anti-1 antisera. Clin Endocrinol 1968; 28:1440-4.
13. Adams DD, Kennedy TH. Occurrence in thyrotoxicosis of a gamma-globulin which protects LATS from neutralization by an extract of thyroid gland. J Clin Endocr Metab 1967; 27:173-7.
14. Smith BR, Hall R. Thyroid-stimulating immunoglobulins in Graves' disease. Lancet 1974; 2:427.
15. Rose NR, Witebsky E. Studies on organ specificity. V. Changes in thyroid glands of rabbits following active immunization with rabbit thyroid extracts. J Immunol 1956; 76:417-27.
16. Anderson JR, Goudie RB, Gray KG, Timbury GC. Autoantibodies in Addison's disease. Lancet 1957; 1:1123-4.
17. Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW. Chronic thyroiditis and autoimmunization. J Am Med Assoc 1957; 164:1439-47.
18. Rose NR, Bona C. Defining criteria for autoimmune diseases. (Witebsky's postulates revisited). Immunol Today 1993; 14:426-9.
19. Todd I, Bottazzo GF. Laboratory investigation of autoimmune endocrine diseases. Clin Immunol Allergy 1985; 5:613-38.
20. Bottazzo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2:1279-82.
21. Song YH, Li Y, Maclaren NK. The nature of autoantigens targeted in autoimmune endocrine diseases. Immunol Today 1996; 17:232-23.
22. Miles J, Charles P, Riches P. A review of methods available for the identification of both organ and non-organ-specific autoantibodies. Ann Clin Biochem 1998; 35:19-47.
23. Greenbaum CJ, Palmer JP, Kuglin B, Kolb H and participating laboratories. Insulin autoantibodies measured by radioimmunoassay methodology are more related to IDDM than those measured by enzyme-linked immunosorbent assay: results of the fourth International Workshop on the standardisation of insulin autoantibody measurement. J Clin Endocrinol Metab 1992; 5:1040-4.
24. Greenbaum CJ, Palmer JP, Nagataki S, Yamaguchi Y, Molenaar JL, Van Beers WAM, Maclaren NK, Lernmark A. Improved specificity of ICA assays in the Fourth International Immunology on Diabetes Serum Exchange Workshop. Diabetes 1992; 41:1570-4.
25. Bingley PJ, Bonifacio E, Mueller PW. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 2003; 52:1128-36.
26. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 1998; 19:673-716.
27. Portman L, Hamada N, Heinrich G, De Groot LJ. Anti-thyroid peroxydase antibody in patients with autoimmune thyroid diseases: possible identification with anti-microsomal antibody. J Clin Endocr Metab 1985; 61:1001-3.
28. Czarnocka B, Ruf J, Ferrand M, Carayon NP, Lissitsky S. Purification of the human thyroid peroxydase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 1985; 190:147-52.
29. Winqvist O, Karlsson FA, Kampe O. 21-hydroxylase, a major autoantigen in Addison's disease. Lancet 1992; 339:1559-62.
30. Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, Rees Smith B, Furmaniak J. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J Clin Endocr Metab 1996; 81:1871-6.
31. Li Y, Song Y, Raiss N, Connor E, Schartz D, Muir A, Maclaren N. Antibodies to the extracellular domain of the calcium-sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 1996; 97:910-4.
32. Baekkeskov S, Aanstoot HJ, Christgau S et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347:151-6.
33. Rabin DU, Pleasic SM, Shapiro JA, Hicks JM, Goldstein DE, Rae PMM. Islet cell antigen 512 is a diabetes-specific islet antigen related to protein tyrosine phosphatases. J Immunol 1994; 152:3183-8.
34. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222:1337-9.
35. + adenosine triphosphatase, the proton pump of the stomach. Gastroenterology 1989; 96:1434-8.
36. Taylor KB, Roitt IM, Doniach D, Couchman KG, Shapland C. Autoimmune phenomena in pernicious anemia: gastric antibodies. Br Med J 1962; 2:1347-52.
37. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 7:797-801.
38. Ekwall O, Hedstrand H, Grimelius L et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 1998; 352:279-83.
39. Manns MP. Autoimmune diseases of the liver. Clin Laboratory Med 1992; 12:25-40.
40. Nishiki M, Murakami Y, Azawa Y, Kato Y. Serum antibodies to human pituitary membrane antigens in patients with autoimmune lymphocytic hypophysitis and infundibuloneurohypophysitis. Clin Endocrinol 2001; 54:327-33.
41. Hedstrand H, Ekwall O, Olsson MJ et al. The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome Type 1. J Biol Chem 2001; 276:35390-5.
42. Song YH, Connor E, Li Y, Zorovich B, Balducci P, Maclaren NK. The role of tyrosinase in autoimmune vitiligo. Lancet 1994; 344:1049-52.
43. Hedstrand H, Ekwall O, Haavik J et al. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome Type 1. Biochem Bioph Res Co 2000; 267:456-61.
44. Patrick J, Lindstrom J. Autoimmune response to acetylcholine receptor. Science 1973; 180:871-2.
45. Colls J, Betterle C, Volpato M, Rees Smith B, Furmaniak J. A new immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in Addison's disease. Clin Chem 1995; 41:375-80.
46. Tanaka H, Powell M, Chen S et al. Autoimmune adrenal diseases - a new sensitive assay for measurement of steroid 21-hydroxylase autoantibodies. J Clin Endocr Metab 1997; 82:1440-6.
47. +, ATPase, the parietal cell antigen. Clin Exp Immunol 1987; 70:604-10.
48. Mariotti S, Anelli S, Ruf J, Bechi R, Czarnocka B, Lombardi A, Carayon P, Pinchera A. Comparison of serum thyroid microsomal and thyroid peroxydase autoantibodies in thyroid diseases. J Clin Endocr Metab 1987; 65:987-93.
49. Neufeld M, Blizzard RM. Polyglandular autoimmune diseases. In: Pinchera A Doniach D Fenzi GF Baschieri L, eds. Symposium on Autoimmune Aspects of Endocrine Disorders. New York: Academic Press, 1980:357-65.
50. Chen QY, Kukreja A, Maclaren NK. The Autoimmune Polyglandular Syndromes. In: De Groot LJ Jameson JL, eds. Endocrinology, 4th edn. Philadelphia: W.B. Saunders, 2001:587-99.
51. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002; 23:327-64.
52. Koury EL, Bottazzo GF, Pontes de Carvalho LC, Wick G, Roitt IM. Predisposition to organ-specific autoimmunity in obese strain (OS) chickens: reactivity to thyroid, gastric, adrenal and pancreatic cytoplasmic antigens. Clin Exp Immunol 1982; 49:273-82.
53. Kooistra HS, Rijnberg A, van den Ingh TS. Polyglandular deficiency syndrome in a boxer dog: thyroid hormone and glucocorticoid deficiency. Vet Quart 1995; 17:59-63.
54. Bartholomaeus WN, O'Donoghue H, Foti D, Lawson CM, Shellam GR, Reed WD. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies. Immunology 1988; 64:397-405.
55. Sakaguchi S, Sakaguchi N. Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. J Immunol 1989; 142:471-80.
56. Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 1981; 60:1653-60.
57. Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003; 361:1881-93.
58. Weetman AP. Graves' disease. N Engl J Med 2000; 343:1236-48.
59. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335:99-107.
60. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001; 358:221-9.
61. Betterle C, Volpato M, Greggio AN, Presotto F. Type 2 polyglandular autoimmune disease (Schmidt' syndrome). J Pediatr Endocr Met 1996; 9:113-23.
62. Papadopoulos KI, Hallengren B. Polyglandular autoimmune syndrome type II in patients with idiopathic Addison's disease. Acta Endocrinol (Copenaghen) 1990; 122:472-8.
63. Myhre AG, Undelien DA, Lovas K et al. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II association related to clinical features. J Clin Endocr Metab 2002; 87:618-23.
64. Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J Clin Endocr Metab 2003; 88:2983-92.
65. Betterle C, Volpato M, Pedini B, Chen S, Rees-Smith B, Furmaniak J. Adrenal-cortex autoantibodies (ACA) and steroid-producing cells autoantibodies (StCA) in patients with Addison's disease: comparison between immunofluorescence and immunoprecipitation assays. J Clin Endocr Metab 1999; 84:618-22.
66. Peterson P, Pitkanen J, Sillanpaa N, Krohn K. Autoimmune polyen-docrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity. Clin Exp Immunol 2004; 135:348-57.
67. Livolsi VA. The pathology of autoimmune thyroid disease: a review. Thyroid 1994; 4:333-9.
68. Weetman A, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocrine Rev 1994; 15:788-830.
69. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes. Diabetes 1965; 14:619-33.
70. Bottazzo GF, Dean BM, McNally MacKay EH, Swift PGF, Gamble R. In situ characterization of autoimmune phenomena and expression of HLA-molecules in the pancreas in diabetic insulitis. N Engl J Med 1985; 313:353-60.
71. McNicol AM. Istopathology of adrenal glands in Addison's disease. In: Bhatt HR James VHT Besser GM Bottazzo GF Keen H, eds. Advances in Thomas Addison's Diseases. Bristol: Journal of Endocrinology Ltd, 1994:5-11.
72. Doppman JL. Adrenal imaging. In: DeGroot LJ Jameson JL, eds. Endocrinology, 4th edn. Philadelphia: W.B. Saunders, 2001:1747-66.
73. Raber W, Gessl A, Nowotny P, Vierhapper H. Thyroid ultrasound versus anti-thyroid peroxydase antibody determination: a cohort study of 451 subjects. Thyroid 2002; 12:725-31.
74. Maclaren N, Riley W. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with Type 1 autoimmune polyglandular syndrome. J Clin Endocr Metab 1986; 62:455-9.
75. Huang W, Connor E, Dela Rosa T et al. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity. J Clin Endocr Metab 1996; 81:2559-63.
76. Kemp EH, Ajjan RA, Husebye ES et al. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients. Clin Endocrinol 1998; 49:609-13.
77. Vaidya B, Pearce S, Kendall-Taylor P. Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure. Clin Endocrinol 2000; 53:403-18.
78. Meyer G, Donner H, Herwig J, Bohlest H, Usadel KH, Badenhoop K. Screening for an AIRE-1 mutation in patients with Addison's disease, Type 1 diabetes, Graves' disease and Hashimoto's thyroiditis as well as in APECED syndrome. Clin Endocrinol 2001; 54:335-8.
79. Albergoni P, Gazzola MV, Slanzi E, Carcassi C, Dal Pra C, Moscon A, Betterle C. HLA-DR and DQ associations with autoimmune Addison's disease in Italian patients. Genes Immunity 2003; 4 (Suppl. 1):S35.
80. Riley WJ, Maclaren N, Neufeld M. Adrenal autoantibodies and Addison's disease in insulin-dependent diabetes mellitus. J Pediatr 1980; 97:191-5.
81. Betterle C, Volpato M, Rees-Smith B et al. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J Clin Endocr Metab 1997; 82:932-8.
82. Betterle C, Volpato M, Rees Smith B et al. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab 1997; 82:939-42.
83. YuL, Brewer KW, Gates S et al. DRB1*04 and DQ Alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J Clin Endocr Metab 1999; 84:328-35.
84. McHardy-Young S, Lessof MH, Maisey M. Serum TSH and thyroid antibody studies in Addison's disease. Clin Endocrinol 1972; 1:45-56.
85. Irvine WJ, Barnes EW. Addison's disease and associated conditions with particular references to premature ovarian failure, diabetes mellitus and hypoparathyroidism. In: Gell PH, Coombs RRA, Lachman P, eds. Clinical Aspects of Immunology. Oxford: Blackwell, 1974:1301-54.
86. Zelissen PM, Bast EJ, Croughs RJ. Associated autoimmunity in Addison's disease. J Autoimmun 1995; 8:121-30.
87. Betterle C, Spadaccino AC, Presotto F, Zanchetta R, Pedini B, Lai M, Greggio NA, Bottazzo GF. The number of markers of pancreatic autoimmunity increases the risk for Type 1 diabetes mellitus (DM) in Italian and English patients with organ-specific autoimmune diseases (OSAD). Ann NY Acad Sci 2002; 958:276-80.
88. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmunity Rev 2003; 2:119-25.
89. + regulator T cells in autoimmune polyglandular syndrome Type 2. J Exp Med 2004; 199:1285-91.
90. Tadmor B, Putterman C, Naparstek Y. Embryonal germ-layer antigens: target for autoimmunity. Lancet 1992; 339:975-8.
91. Roep BO. Autoreactive T cells in endocrine/organ-specific autoimmunity: why has progress been so slow? Springer Semin Immunopathol 2002; 24:261-71.
92. Gillis D, Volpé R, Daneman D. A young boy with a thyroid yo-yo. J Pediatr Endocrinol Metab 1998; 11:467-70.
93. Kannan CR. Addison's disease. In: Kannan CR, ed. The Adrenal Gland. London: Plenum Medical Book Co, 1988:31-96.
94. Schatz DA, Winter WE. Autoimmune polyglandular syndrome II. clinical syndrome and treatment. Endocrinol Metab Clin N Am 2002; 31:339-52.